MetaCap

AbCellera Biologics Statistics

NASDAQ: ABCLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.69-0.78 (-7.45%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AbCellera Biologics by the numbers

AbCellera Biologics has a market capitalization of $3.16 billion based on 326.62M shares outstanding. With trailing EPS of $-0.48, AbCellera Biologics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.2% below its 50-day average and 30.6% above its 200-day average.

Average daily trading volume is 4.34M shares, or about $42.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABCL valuation vs. peer median

ABCL compared with the median of 8 peer companies
MetricABCLPeer medianDifference
Market cap$3.16B$3.13B+1%
Avg. volume4.34M2.42M+79%

Peer median across 8 companies: VKTX, XERS, BHC, ARQT, AMLX, LEGN, ACAD, VRDN.

Valuation

Price / sales (latest FY)
42.13
EPS (TTM)
$-0.48

Price and trading

Previous close
10.47
Open
10.10
Day range
9.58 – 10.26
52-week range
2.75 – 15.02
52-week change
+176.07%
Beta
—
Volume
4.24M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.16B
Forward Pe
-13.77
Eps
-0.48
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
15.02
Week52 Low
2.75
Avg Volume
4.34M
Shares Outstanding
326.62M
Ma50
12.30
Ma200
7.42
Earnings Date
Nov 9, 2026
Pct From52w High
-35.46%
Pct From52w Low
253.01%

Related